Lawful CBD Sales In US Might Swing On Closing Door To Private Safety Data

"I think dietary supplement is a pathway where the agency can get data to protect public health and folks in the industry that have spent time and treasure on CBD will get a chance to try and market it," says Bob Durkin, former FDA ODSP deputy director. NDI notifications for CBD ingredients should focus on safety in the formulation of a particular product, not about the substance generally, he says.